TRENTON, N.J. - (Mealey's) The New Jersey Supreme Court on Aug. 9 ruled that some failure-to-warn claims and some breach of warranty claims involving the Cordis Cypher drug-coated coronary stent may survive federal preemption, a ruling that applies... Read More
BOSTON - (Mealey's) A federal judge in Massachusetts on April 27 dismissed a putative securities class action stemming from Boston Scientific Corp.'s recalled Taxus and Taxus Express2 stents, saying that the market was aware of problems with the... Read More